Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-Trimethoprim PET/CT Imaging in Bacterial Infection
NCT03424525Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2018
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 11C-trimethoprim in bacterial infection (2 cohorts), sponsored by University of Pennsylvania. Primary endpoint: Kinetics of uptake of [11C]TMP in human patients at 3 years. Started Feb 2018; status: completed.
02
Drugs
11C-trimethoprim
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03424525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03424525.